Proxima Bio

Proxima Bio, Inc. was formed as a New York corporation on June 4, 2026, filed by the company itself as its own registered agent, meaning the owner or an officer handled the paperwork directly, without a formation service. The company is in the biotechnology sector, specifically developing proximity-based medicines, and its website confirms the business name and New York address, matching the filing details. The site is modern, built with a JavaScript framework and responsive design, and uses HTTPS. The domain was registered on June 29, 2024, 705 days before the filing, suggesting the business was planned well in advance. We estimate revenue under $100K, as this is a pre-commercial biotech startup that recently raised an $80 million seed round but likely has little to no revenue yet. The employee count is estimated between 26 and 100, based on roughly 40, 50 named individuals on the team page. The company appears to be a brick-and-mortar operation in Manhattan, requiring lab and office space. No annual report or EIN on file yet. Notably, the domain was registered nearly two years before the formal incorporation, indicating a long planning phase, and the company filed itself rather than using a service, which is common for startups with legal counsel in-house.